• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献 >>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

小剂量舒芬太尼联合帕瑞昔布钠对瑞芬太尼麻醉术后痛觉过敏的预防效应

Preventive effect of low-dose sufentanil combined with parecoxib sodium for hyperalgesia of remifentanil anesthesia after postoperative

摘要:

目的 探讨小剂量舒芬太尼联合帕瑞昔布钠对瑞芬太尼麻醉后术后痛觉过敏的预防效应.方法 将120例择期全麻下行腹部手术患者按随机数字表法分为三组,术中均给予瑞芬太尼静脉输注,术毕前30 min A组静脉注射舒芬太尼0.1μg/kg,B组静脉注射舒芬太尼0.2μg/kg,两组均联用40 mg帕瑞昔布钠,C组注射生理盐水5 ml.比较三组患者术后苏醒时间、拔管时间、术后1、2、6、12、24h视觉模拟评分法(VAS)评分以及术后24h追加镇痛药物例数与发生躁动情况.结果 B组苏醒时间与拔管时间明显长于A组和C组[(10.9±1.3)min vs (8.6 ±0.6)min、(8.2±0.7) min;(14.0±2.1)min vs(10.7 ±2.2)min、(10.8±1.2)min,P均<0.01];各时点A组、B组VAS评分均明显低于C组(P<0.01);C组术后24 h追加镇痛药物例数、发生躁动例数明显多于A组、B组(P<0.01),A组术后24h追加镇痛药物例数、发生躁动例数多于B组,但差异无统计学意义(P>0.05).结论 小剂量舒芬太尼联合帕瑞昔布钠可有效抑制瑞芬太尼麻醉后诱发的疼痛过敏,且不会出现苏醒时间及拔管时间延迟现象,安全性高.

更多
abstracts:

Objective To explore preventive effect of low-dose sufentanil combined with parecoxib sodium for hyperalgesia of remifentanil anesthesia after postoperative.Methods A total of 120 patients undergoing elective abdominal surgery under general anesthesia was randomly divided into three groups that were given intraoperative remifentanil infusion.At the 30 minutes before surgery,group A were given intravenous sufentanil 0.1 μg/kg combined with 40 mg parecoxib sodium,group B were given intravenous sufentanil 0.2 μg/kg combined with 40 mg parecoxib sodium,and group C were given normal saline 5 ml.Postoperative recovery time,extubation time,postoperative 1,2,6,12,and 24 h visual analog scale (Visual Analogue Scale/Score,VAS) score,and after 24 h additional analgesia number of cases and the restless occurrence of three groups were compared.Results Awakening time and extubation time of group B was significantly longer than groups A and C [(10.9 ± 1.3) min vs (8.6 ± 0.6) min,(8.2 ± 0.7) min;(14.0 ± 2.1) min vs (10.7 ± 2.2) min,(10.8 ± 1.2) min,all P < 0.01].Each point VAS scores of groups A and B were significantly lower than group C (P <0.01).After 24 h,the number of cases additional analgesic medication,and restlessness occurrence of group C were significantly more than the number of cases of groups A and B (P < 0.01),the number of cases and the restless occurrence after 24 h additional analgesic drugs of group A were more than group B,but there was no significant difference between two groups (P > 0.05).Conclusions Low dose sufentanil together with parecoxib sodium can inhibit after-remifentanil-induced hyperalgesia,and will not appear awakening time and extubation time delays and safe.

More
  • 浏览:109
  • 下载:52

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷